Wolf, Jule
Kurz, Steffen
Rothe, Thomas
Serpa, Marco
Scholber, Jutta
Erbes, Thalia
Gkika, Eleni
Baltas, Dimos
Verma, Vivek
Krug, David
Juhasz-Böss, Ingolf
Grosu, Anca-Ligia
Nicolay, Nils H.
Sprave, Tanja
Funding for this research was provided by:
Universitätsklinikum Freiburg
Article History
Received: 21 April 2022
Accepted: 1 June 2022
First Online: 21 June 2022
Declarations
:
: The study was approved by the institutional ethical review committee of the Albert-Ludwigs-University of Freiburg (reference no. 453/19) and was performed in accordance with the relevant guidelines and regulations. The need for patient consent was waived by the ethics committee.
: Not applicable.
: D. Krug has received honoraria from Merck Sharp & Dohme and Pfizer as well as research funding from Merck KGaA outside the submitted work. T. Sprave has received honoraria from Hologic outside the submitted work. The other authors declare that they have no competing interests.